UBS AM’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,084	Closed	-$166K	–	2521
2020 Q2	$166K	Buy	+12,084	New	+$166K	﹤0.01%	2419
2019 Q2	–	Sell	-7,156	Closed	-$203K	–	2895
2019 Q1	$203K	Buy	+7,156	New	+$203K	﹤0.01%	2454